According to Avid Bioservices 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.31501. At the end of 2023 the company had a P/S ratio of 2.76.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.76 | -64.8% |
2022 | 7.85 | -55.68% |
2021 | 17.7 | 213.25% |
2020 | 5.65 | 20.79% |
2019 | 4.68 | -41.81% |
2018 | 8.04 | 165.73% |
2017 | 3.03 | 94.36% |
2016 | 1.56 | -76.49% |
2015 | 6.62 | -49.61% |
2014 | 13.1 | 50.71% |
2013 | 8.72 | 27.93% |
2012 | 6.82 | 21.77% |
2011 | 5.60 | 45.37% |
2010 | 3.85 | -18.39% |
2009 | 4.72 | -51.59% |
2008 | 9.75 | -56.76% |
2007 | 22.5 | -69.79% |
2006 | 74.6 | 32.49% |
2005 | 56.3 | 46.15% |
2004 | 38.5 | -47.3% |
2003 | 73.1 | 69.4% |
2002 | 43.2 | 18.52% |
2001 | 36.4 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Neogen NEOG | 2.83 | -14.63% | ๐บ๐ธ USA |
Natera NTRA | 10.4 | 212.39% | ๐บ๐ธ USA |